Non-Invasive Prenatal Testing

Choosing NIPT/NIPS genetic testing in India offers several significant benefits for expectant parents.

• Non-invasive: The NIPT/NIPS test procedure is simple and involves only a blood draw from the mother, making it non-invasive and safe for both mother and baby.
• Early Detection: Screens for chromosomal abnormalities early in pregnancy.
• High Accuracy: Over 99.9% sensitivity for conditions like Down syndrome.
• Peace of Mind: Gives you reassurance and early options for managing potential conditions.
• Informed Decisions: Helps you and your doctor plan the best care for your pregnancy.
• Genetic Counselling: Experts are available to explain the results and guide you on the next steps.

• Non-invasive prenatal testing/screening is a simple process that begins with booking the test either online on the MedGenome website or through a healthcare provider at a MedGenome Lab.
• Pre-test preparation is minimal, with no fasting required.
• On the test day, a simple blood draw takes about 30 minutes.
• The procedure is quick and comfortable, allowing patients to relax during the process.
• After the test, your blood is checked for the fetal DNA and any possible issues.
• Results are typically delivered within a week through MedGenome’s secure portal or via the healthcare provider, ensuring timely access to crucial information.

Non-invasive prenatal testing/screening is a simple and safe process that begins with a blood draw from the mother, typically performed after the 10th week of pregnancy. It is recommended for individuals with high-risk pregnancies, those of advanced maternal age, or with a family history of genetic disorders. The test can also be beneficial for women who have experienced previous miscarriages or stillbirths and for those expecting multiple pregnancies. After collection, the blood sample is sent for examination to detect fetal DNA and check for chromosomal abnormalities.

The NIPT/NIPS blood test is recommended for all pregnant women, regardless of maternal or gestational age. It is especially advised for those who:

• Are aged 35 years or older.

• Have a high-risk result on maternal serum screening.

• Are identified as high-risk through ultrasound findings.

• Prefer non-invasive testing options.

• Have a family history of chromosomal disorders.

• Have experienced previous miscarriages.

• Seek early detection of chromosomal abnormalities.

The NIPT/NIPS test results provide information about the likelihood of certain chromosomal conditions, such as Down syndrome, trisomy 18, and trisomy 13.
A positive result means your baby might have a higher chance of having these conditions, while a negative result generally indicates a lower risk, but it’s essential to remember that NIPT is a screening test and not a diagnostic tool.
If the results are high risk, your doctor may recommend further invasive diagnostic testing.

NIPT/NIPS can be done anytime after 10 weeks. However, it’s usually performed after an ultrasound test.

NIPT/NIPS during pregnancy screens for several chromosomal abnormalities, including:

• Trisomy 18 (Edwards syndrome).
• Trisomy 21 (Down syndrome).
• Trisomy 13 (Patau syndrome).

These conditions are caused by the presence of an extra chromosome.
Extra chromosomes can lead to developmental and health challenges in the fetus. The test works by analysing tiny pieces of fetal DNA present in the maternal bloodstream.

Some NIPT/NIPS panels can also identify:

• Sex chromosome aneuploidies.
• Rare autosomal aneuploidies.

MedGenome’s non-invasive prenatal testing/screening offers several advantages that set it apart from other prenatal testing options:

• First, it uses advanced technology to detect chromosomal abnormalities, including trisomy 21, 18, and 13, and sex chromosomes with greater accuracy.
• The test process is non-invasive, ensuring patient comfort and safety.
• Additionally, MedGenome lab provides timely NIPT/NIPS test reports, typically within a week, enabling prompt decision-making.
• With 4 peer-reviewed publications, MedGenome is also CAP-accredited.
• Our genetic counselling services are also available for interpretation and guidance following results. MedGenome’s commitment to quality and comprehensive care makes our NIPT testing / screening an optimal choice for expectant parents.